Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glypican-2 (GPC2) is a cell surface heparan sulfate proteoglycan involved in developmental processes, particularly in the nervous system. It functions in cell adhesion, axon guidance, and as a co-receptor for several signaling pathways, including Wnt, Hedgehog, FGF, and BMP signaling. GPC2 exhibits restricted expression in normal adult tissues but is highly overexpressed in several cancers, including neuroblastoma, medulloblastoma, retinoblastoma, small-cell lung cancer and prostate cancer, making it an attractive target for cancer immunotherapy.
Immunotherapies (antibodies, CAR-T cells) targeting GPC2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glypican-2 (GPC2).